Curia New York, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 33 Riverside Avenue, Rensselaer, New York (NY) 12144, United States (USA)
- Operations here
- analysisapi manufactureparticle size reduction
- FDA identifiers
- FEI 1310298 · DUNS 124193793
Recent inspection flagged official action
FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 8 drugs, 1 already in shortage. A supply problem here can ripple to all of them.
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- OAIDrug Quality Assurance2026-02-05
- VAIDrug Quality Assurance2023-11-01
- VAIDrug Quality Assurance2017-11-09
- VAIDrug Quality Assurance2015-05-22
- VAIDrug Quality Assurance2014-01-15
- VAIDrug Quality Assurance2013-01-30
- NAIDrug Quality Assurance2012-03-29
- VAIDrug Quality Assurance2010-04-07
Drugs this plant is listed as making
8 distinct drugs across 23 products name this site in their FDA label.
- BelinostatAcrotech Biopharma Inc
- brigatinibTakeda Pharmaceuticals America, Inc.
- duvelisibSecura Bio, Inc
- Lisdexamfetamine Dimesylatein shortageTakeda Pharmaceuticals America, Inc.
- Primaquine PhosphateSanofi-Aventis U.S. LLC
- Sodium Nitrite and Sodium ThiosulfateHope Pharmaceuticals
- Sodium ThiosulfateHope Pharmaceuticals
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.